SPL 0.00% 10.5¢ starpharma holdings limited

Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-65

  1. 3,318 Posts.
    lightbulb Created with Sketch. 780
    The clearest and most logical summary yet from Teddyward.

    To paraphrase for the usual suspects who have eyes that glaze over reading a post of more than 3 sentences:

    Apparently the post-market Viraleze trial results were so outstanding, so remarkably good, so ground-breaking that Starpharma either forget to or declined to communicate this to the market in the ASX announcement.

    I think that’s the gist of Teddy’s post.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.